BoldtV, StacherE, HalbwedlI. Positioning of necrotic lobular intraepithelial neoplasia (LIN, grade 3) within the sequence of breast carcinoma progression. Genes Chromosomes Cancer.2010; 49: 463–470.
2.
BratthauerGL, TavassoliFA. Lobular intraepithelial neopla-sia: previously unexplored aspects assessed in 775 cases and their clinical implications. Virchows Arch.2002; 440: 134–138.
3.
ChenY-Y, HwangES, RoyR. Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breast. Am J Surg Pathol.2009; 33: 1683–1694.
4.
FadareO, DadmaneshF, Alvarado-CabreroI. Lobular intraepithelial neoplasia with comedo-type necrosis. A clinicopathologic study of 18 cases. Am J Surg Pathol.2006; 30: 1445–1453.
5.
FooteFWJ, StewartFW. Lobular carcinoma in situ. A rare form of mammary cancer. Am J Pathol.1941; 12: 491–496.
6.
HaagensenCD, LaneN, LattesR. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer.1978; 42: 737–769.
7.
LuYJ, OsinP, LakhaniSR. Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia. Cancer Res.1998; 58: 4721–4727.
8.
MastracciTL, TjanS, BaneAL. E-cadherin alterations in atypical lobular hyperplasia and lobular carcinoma in situ of the breast. Mod Pathol.2005; 18: 741–751.
9.
PalaciosJ, SarrioD, Garcia-MaciasMC. Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast. Mod Pathol.2003; 16: 674–678.
10.
Reis-FilhoJS, SimpsonPT, JonesC. Pleomorphic lobular carcinoma of the breast: role of comprehensive molecular pathology in characterization of an entity. J Pathol.2005; 207: 1–13.
11.
RosenPP, KosloffC, LiebermanPH. Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol.1978; 2: 225–251.
